Article | April 10, 2025

Clinical Apheresis: Unlocking Quality For CAR-T And Cell-Based Therapies

By Stephanie Dormesy, MPH, and Carolina Betancourt, RN, Comprehensive Cell Solutions

GettyImages-1163687229-cells-CAR-T-human

Comprehensive Cell Solutions (CCS) stands apart as a full-service contract development and manufacturing organization (CDMO) with unparalleled depth and breadth of experience in cell sourcing, (apheresis and cryopreserved cord blood), process and analytical development, manufacturing, and cryopreservation services.

CCS also is differentiated as a mobile team because we offer a comprehensive variety of services tailored to specific client needs. These services include the transportation of equipment and supplies as well as skilled professionals performing the requested procedures at partner facilities.

And, given CCS’s large and continually expanding footprint, we have the global reach to attract donors and patients beyond our immediate service area. This enables CCS to work with biopharma sponsors to scale up the collection process, ensuring a consistent and sufficient supply of cells for clinical trials and commercial use.

access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Outsourced Pharma? Subscribe today.

Subscribe to Outsourced Pharma X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Outsourced Pharma

Comprehensive Cell Solutions, A Business Unit of NYBC Enterprises